UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

CAMBIUM NETWORKS CORPORATION

(Exact name of Registrant as Specified in Its Charter)

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(e) As previously reported on the Current Report on Form 8-K filed with the Securities and Exchange Commission on April 18, 2022, effective as of April 13, 2022 (the "Effective Date"), Cambium Networks Corporation (the "Company") announced the departure of Stephen Cumming from his position as Chief Financial Officer of the Company. In connection with Mr. Cumming's departure, Mr. Cumming and the Company entered into a separation agreement on April 27, 2022, which provides for (i) a lump sum payment equal to six months of his base salary, (ii) reimbursement of the cost of the premiums for continued group health insurance coverage in accordance with federal law (COBRA), through the earlier of six months or the date on which he first becomes eligible to obtain other group health insurance coverage, in the event that Mr. Cumming timely elects to obtain such coverage, and (iii) vesting of all of Mr. Cumming's outstanding but unvested restricted share units. In addition, the Company has agreed to extend the post-termination period during which Mr. Cumming may exercise his outstanding vested options to December 31, 2022. Mr. Cumming's separation benefits are conditioned upon his execution and non-revocation of a release of claims in favor of the Company.

Item 9.01(d) Exhibits.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.